The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
The validity of circulating microRNAs in oncology: Five years of challenges and contradictions
Open accessAbstract
MicroRNAs (miRNAs) in circulation have received an increasing amount of interest as potential minimal invasive diagnostic tools in oncology. Several diagnostic, prognostic and predictive signatures have been proposed for a variety of cancers at different stages of disease, but these have not been subjected to a critical review regarding their validity: reproducible identification in comparable studies and/or with different platforms of miRNA detection. In this review, we will critically address the results of circulating miRNA research in oncology that have been published between January 2008 and June 2013 (5.5 years), and discuss pre‐analytical challenges, technological pitfalls and limitations that may contribute to the non‐reproducibility of circulating miRNA research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Skol, A. D., Scott, L. J., Abecasis, G. R., & Boehnke, M. (2006) · Nature Genetics · doi:10.1038/ng1706 · Cited by 1,286
Ng, E. K. O., Chong, W. W. S., Jin, H., Lam, E. K. Y., Shin, V. Y., Yu, J., Poon, T. C. W., Ng, S. S. M., & Sung, J. J. Y. (2009) · Gut · doi:10.1136/gut.2008.167817 · Cited by 1,151
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
Pritchard, C. C., Kroh, E., Wood, B., Arroyo, J. D., Dougherty, K. J., Miyaji, M. M., Tait, J. F., & Tewari, M. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0370 · Cited by 879 · cited 1×
“as solid tumor biomarkers actually correlate well with blood cell counts (Pritchard et al., 2012).”
BackgroundInterpretation of tests of heterogeneity and bias in meta-analysis
Ioannidis, J. P. A. (2008) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.00986.x · Cited by 696 · cited 1×
“the results identified as “most significant” in the study are subject to winner’s curse (Ioannidis, 2008; Faye et al., 2011).”
A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
Zhao, H., Shen, J., Medico, L., Wang, D., Ambrosone, C. B., & Liu, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013735 · Cited by 398 · cited 1×
“Fewer than half of gastric cancer signatures center onmiR21, with five more diagnostic signatures showing no overlap whatsoever (Gorur et al., 2012; Konishi et al., 2012; C. Li et al., 2013; H. Liu et al., 2012; Song et al., 2012; Tsujiura et al., 2010; Wang and Zhang, 2012; Zhao et al., 2010).”
BackgroundPlasma processing conditions substantially influence circulating microRNA biomarker levels
Cheng, H. H., Yi, H. S., Kim, Y., Kroh, E. M., Chien, J. W., Eaton, K. D., Goodman, M. T., Tait, J. F., Tewari, M., & Pritchard, C. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064795 · Cited by 317
Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
Liao, J., Yu, L., Mei, Y., Guarnera, M., Shen, J., Li, R., Liu, Z., & Jiang, F. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-198 · Cited by 293
miR-21 Regulates Skin Wound Healing by Targeting Multiple Aspects of the Healing Process
Wang, T., Feng, Y., Sun, H., Zhang, L., Hao, L., Shi, C., Wang, J., Li, R., Ran, X., Su, Y., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.08.022 · Cited by 192
Cited by
MicroRNAs in cancer: biomarkers, functions and therapy
Hayes, J., Peruzzi, P. P., & Lawler, S. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.06.005 · Cited by 2,049
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Condrat, C. E., Thompson, D. C., Barbu, M. G., Bugnar, O. L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S. M., & Voinea, S. C. (2020) · Cells · doi:10.3390/cells9020276 · Cited by 1,344
Clinical utility of circulating non-coding RNAs — an update
Anfossi, S., Babayan, A., Pantel, K., & Calin, G. A. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0035-x · Cited by 450
Circulating microRNAs as potential biomarkers for endometriosis
Cho, S., Mutlu, L., Grechukhina, O., & Taylor, H. S. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.02.013 · Cited by 181
Altered Extracellular Vesicle MicroRNA Expression in Ischemic Stroke and Small Vessel Disease.
van Kralingen, J. C., McFall, A., Ord, E. N. J., Coyle, T. F., Bissett, M., McClure, J. D., McCabe, C., Macrae, I. M., Dawson, J., & Work, L. M. (2019) · Translational Stroke Research · doi:10.1007/s12975-018-0682-3 · Cited by 47
Metadata
- Authors
- Jarry, J., Schadendorf, D., Greenwood, C., Spatz, A., & van Kempen, L. C.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2014-03-06
- Volume
- 8
- Issue
- 4
- Pages
- 819-829
- ISSN
- 1574-7891 (ISSN-L)
- 1878-0261
- OpenAlex
- W2100104641
- Cited by
- 162
- References
- 8
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The validity of circulating microRNAs in oncology: Five years of challenges and contradictions. https://app.cochat.ai/papers/10.1016/j.molonc.2014.02.009
- The paper
- Jarry, J., Schadendorf, D., Greenwood, C., Spatz, A., & van Kempen, L. C. (2014). The validity of circulating microRNAs in oncology: Five years of challenges and contradictions. Molecular Oncology. https://doi.org/10.1016/j.molonc.2014.02.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.